Biotechnology
625 companies in this industry
Insider Buys (30d)
96
$177.78M
Insider Sells (30d)
396
$506.18M
Top Companies by Market Cap
VRTXVertex Pharmaceuticals Incorporated
$113.41BREGNRegeneron Pharmaceuticals, Inc.
$65.47BARGXargenx SE
$45.82BALNYAlnylam Pharmaceuticals, Inc.
$40.46BRVMDRevolution Medicines, Inc.
$31.73BBNTXBioNTech SE
$24.56BRPRXRoyalty Pharma plc
$23.60BUTHRUnited Therapeutics Corporation
$23.12BROIVRoivant Sciences Ltd.
$20.49BINSMInsmed Incorporated
$20.41BRecent Insider Trades
| Date | Ticker | Company | Insider | Role | Type | Shares | Avg Price | Value |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | ADTX | Aditxt, Inc. | HRT FINANCIAL LP | 10 percent owner | Sell | 2,833,463 | $0.01 | $39.7K |
| Jun 12, 2026 | SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | officer: Chief Commercial Officer | Sell | 25,000 | $10.00 | $250.0K |
| Jun 12, 2026 | SNDX | Syndax Pharmaceuticals, Inc. | Botwood Nicholas A.J. | officer: Head of R&D, CMO | Sell | 65,515 | $18.07 | $1.18M |
| Jun 12, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $549.23 | $5.22M |
| Jun 12, 2026 | LGND | Ligand Pharmaceuticals Incorporated | LAMATTINA JOHN L | director | Sell | 4,591 | $250.88 | $1.15M |
| Jun 12, 2026 | SMMT | Summit Therapeutics Inc. | DUGGAN ROBERT W | director, 10 percent owner, officer: Co-Chief Executive Officer | Buy | 3,810,000 | $13.12 | $49.99M |
| Jun 12, 2026 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | officer: Chief Operating Officer | Sell | 4,674 | $16.82 | $78.6K |
| Jun 12, 2026 | UTHR | United Therapeutics Corporation | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $549.29 | $5.49M |
| Jun 12, 2026 | LQDA | Liquidia Corporation | Bloch Stephen M | director | Sell | 388,223 | $68.61 | $26.63M |
| Jun 12, 2026 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | officer: Chief Medical Officer | Sell | 8,519 | $24.20 | $206.2K |
| Jun 12, 2026 | APGE | Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | Sell | 20,000 | $83.38 | $1.67M |
| Jun 12, 2026 | LGND | Ligand Pharmaceuticals Incorporated | Aryeh Jason | director | Sell | 5,000 | $250.00 | $1.25M |
| Jun 12, 2026 | CMND | Clearmind Medicine Inc. | HRT FINANCIAL LP | 10 percent owner | Buy | 2,159,052 | $0.15 | $330.3K |
| Jun 12, 2026 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | director, 10 percent owner, officer: Co-Chief Executive Officer | Buy | 3,810,000 | $13.12 | $49.99M |
| Jun 12, 2026 | CMND | Clearmind Medicine Inc. | HRT FINANCIAL LP | 10 percent owner | Sell | 225,191 | $0.12 | $27.7K |
| Jun 12, 2026 | SPRY | ARS Pharmaceuticals, Inc. | Fitzpatrick Alexander A | officer: Chief Legal Officer | Sell | 3,355 | $10.00 | $33.5K |
| Jun 12, 2026 | ORKA | Oruka Therapeutics, Inc. | Dambkowski Carl | director | Sell | 35,000 | $70.13 | $2.45M |
| Jun 11, 2026 | GUTS | Fractyl Health, Inc. Common Stock | Sheffield Ian | director | Buy | 35,000 | $0.73 | $25.5K |
| Jun 11, 2026 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Jenkins John Kenneth | director | Sell | 4,800 | $7.91 | $38.0K |
| Jun 11, 2026 | NUVB | Nuvation Bio Inc. | Mashal Robert | director | Buy | 25,000 | $4.73 | $118.3K |
| Jun 11, 2026 | LYEL | Lyell Immunopharma, Inc. | Shook David | officer: Chief Medical Officer | Sell | 1,977 | $12.64 | $25.0K |
| Jun 11, 2026 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Kung Winston | director | Sell | 2,026 | $7.91 | $16.0K |
| Jun 11, 2026 | HOWL | Werewolf Therapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | 10 percent owner | Sell | 678,226 | $0.37 | $253.6K |
| Jun 11, 2026 | AXSM | Axsome Therapeutics, Inc. | JEFFS ROGER | director | Sell | 572 | $247.65 | $141.7K |
| Jun 11, 2026 | GUTS | Fractyl Health, Inc. Common Stock | BRADLEY WILLIAM | director | Buy | 68,493 | $0.73 | $50.3K |
| Jun 11, 2026 | ARTV | Artiva Biotherapeutics, Inc. | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 1,027,722 | $7.44 | $7.65M |
| Jun 11, 2026 | CDXS | Codexis, Inc. | De Vre Raymond | director | Sell | 2,605 | $2.37 | $6.2K |
| Jun 11, 2026 | STTK | Shattuck Labs, Inc. | SIEGALL CLAY B | director | Buy | 62,500 | $4.00 | $250.0K |
| Jun 11, 2026 | NUVL | Nuvalent, Inc. | Noci Darlene | officer: Chief Development Officer | Sell | 20,000 | $122.81 | $2.46M |
| Jun 11, 2026 | GUTS | Fractyl Health, Inc. Common Stock | Rajagopalan Harith | director, officer: Chief Executive Officer | Buy | 25,000 | $0.73 | $18.3K |
| Jun 11, 2026 | ADTX | Aditxt, Inc. | HRT FINANCIAL LP | 10 percent owner | Sell | 878,659 | $0.03 | $29.0K |
| Jun 11, 2026 | ADTX | Aditxt, Inc. | HRT FINANCIAL LP | 10 percent owner | Buy | 2,148,823 | $0.04 | $83.5K |
| Jun 11, 2026 | GYRE | Gyre Therapeutics, Inc. | Ye Weiguo | officer: Chief Operating Officer | Sell | 20,918 | $6.16 | $128.9K |
| Jun 11, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $545.83 | $5.19M |
| Jun 11, 2026 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Altmeyer Anne | director | Sell | 2,412 | $7.91 | $19.1K |
| Jun 11, 2026 | PTGX | Protagonist Therapeutics, Inc. | Waddill William D. | director | Sell | 9,000 | $107.68 | $969.1K |
| Jun 10, 2026 | UTHR | United Therapeutics Corporation | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $549.32 | $5.22M |
| Jun 10, 2026 | HOWL | Werewolf Therapeutics, Inc. | EVNIN LUKE | director | Sell | 76,928 | $0.37 | $28.5K |
| Jun 10, 2026 | MGX | Metagenomi, Inc. Common Stock | Irish Jian | director, officer: See Remarks | Sell | 3,737 | $1.30 | $4.9K |
| Jun 10, 2026 | MRVI | Maravai LifeSciences Holdings, Inc. | ORESHACK KURT | officer: General Counsel | Sell | 50,000 | $5.08 | $254.0K |
| Jun 10, 2026 | CVKD | Cadrenal Therapeutics, Inc. Common Stock | Pham Quang X | director, 10 percent owner, officer: Chairman, CEO and Interim CFO | Sell | 22,385 | $4.17 | $93.3K |
| Jun 10, 2026 | ABOS | Acumen Pharmaceuticals, Inc. | Fountain Nathan B | director | Sell | 6,400 | $2.23 | $14.3K |
| Jun 10, 2026 | AXSM | Axsome Therapeutics, Inc. | Mahony Susan | director | Sell | 600 | $241.70 | $145.0K |
| Jun 10, 2026 | MGX | Metagenomi, Inc. Common Stock | Wapnick Pamela | officer: Chief Financial Officer | Sell | 2,884 | $1.30 | $3.7K |
| Jun 10, 2026 | INSM | Insmed Incorporated | Lewis William | director, officer: Chair and CEO | Sell | 6,515 | $94.03 | $612.6K |
| Jun 10, 2026 | ADTX | Aditxt, Inc. | Gong Sandie | 10 percent owner | Sell | 100,000 | $0.07 | $6.9K |
| Jun 10, 2026 | LQDA | Liquidia Corporation | Khindri Sanjeev | officer: Chief Development Officer | Sell | 4,134 | $65.46 | $270.6K |
| Jun 10, 2026 | MGX | Metagenomi, Inc. Common Stock | Wein Matthew | officer: See Remarks | Sell | 558 | $1.30 | $724.84 |
| Jun 10, 2026 | LQDA | Liquidia Corporation | Bloch Stephen M | director | Sell | 220,835 | $64.64 | $14.27M |
| Jun 10, 2026 | NUVL | Nuvalent, Inc. | Porter James Richard | director, officer: President and CEO | Sell | 30,000 | $88.53 | $2.66M |
Showing 1–50 of 492
1 / 10
...